Strategic Relationship
IVERIC Bio Enters Into Strategic Manufacturing Relationship With Catalent’s Paragon Gene Therapy For Orphan Inherited Retinal Diseases
Catalent
PR-M06-19-NI-034Jun 20, 2019
M&A
Catalent Makes Moves to Enter Gene Therapy Market with the Purchase of Paragon Bioservices
Nice Insight
PAO-M04-19-NI-024Apr 18, 2019
Award
Paragon Bioservices Recognized as Life Science Company of the Year by Maryland Tech Council
Paragon Bioservices
PR-M05-18-NI-085May 23, 2018